In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome

Respiration

Volumn 69, Issue 3, 2002, Pages 229-234

  Geiser, Thomas ^a   Buck, Florian ^a   Meyer, Beat J ^b   Bassetti, Claudio ^c   Haeberli, André ^a   Gugger, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Neurologische Universitatsklinik Bern   (Switzerland)

Author keywords

Cardiovascular events; Obstructive sleep apnea syndrome; Platelet activation; Platelet derived microparticles; Stroke

Indexed keywords

CD63 ANTIGEN; PADGEM PROTEIN; PROCOAGULANT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME; THROMBOCYTE ACTIVATION;

AGED; ANTIGENS, CD; EPITOPES; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; SLEEP; SLEEP APNEA, OBSTRUCTIVE;

EID: 0036311873     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063625     Document Type: Article

References (23)

1. Long-term outcome for obstructive sleep apnea syndrome patients: Mortality
2. Association of sleep apnea with myocardial infarction in men
3. Sleep apnea in acute cerebrovascular diseases. Final report on 128 patients
4. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians
5. Circadian variation in the timing of stroke onset: A meta-analysis
6. Night time versus daytime transient ischaemic attack and ischaemic stroke: A prospective study of 110 patients
7. Snoring as a risk factor for ischemic heart disease and stroke in men
8. Snoring as a risk factor for sleep-related brain infarction
9. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure
10. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death
11. Membrane-bound enzyme complexes in blood coagulation
12. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias
13. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves
14. Comparison of ResMed AutoSet (version 3.03) with polysomnography in the diagnosis of the sleep apnoea/hypopnoea syndrome
15. Rebound after cessation of oral anticoagulant therapy: The biochemical evidence
16. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
17. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force
18. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea
19. Blood pressure, catecholamines and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment
20. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome
21. Platelet function in patients with obstructive sleep apnea syndrome
22. Clinical utility of available methods for determining platelet function
23. Blood platelet activation evaluated by flow cytometry: Optimised methods for clinical studies